Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Anticancer properties of bromelain: State-of-the-art and recent trends

  • Raffaele Pezzani
  • , Manuel Jiménez-Garcia
  • , Xavier Capó
  • , Eda Sönmez Gürer
  • , Farukh Sharopov
  • , Tchokouaha Yamthe Lauve Rachel
  • , David Ntieche Woutouoba
  • , Antonio Rescigno
  • , Stefania Peddio
  • , Paolo Zucca
  • , Patrick Valere Tsouh Fokou
  • , Miquel Martorell
  • , Zehra Gulsunoglu-Konuskan
  • , Alibek Ydyrys
  • , Tynybekov Bekzat
  • , Tussupbekova Gulmira
  • , Christophe Hano
  • , Javad Sharifi-Rad
  • , Daniela Calina
  • University of Padua
  • Associazione Italiana per la Ricerca Oncologica di Base
  • University of the Balearic Islands
  • Cumhuriyet University
  • Academy of Sciences of the Republic of Tadzhikistan
  • Institute of Medical Research and Medicinal Plants Studies (IMPM)
  • Université de Yaoundé I
  • University of Cagliari
  • University of Bamenda
  • Universidad de Concepción
  • Istanbul Aydin University
  • Al Farabi Kazakh National University
  • George Washington University
  • Université d'Orléans
  • Universidad del Azuay
  • Craiova University of Medicine and Pharmacy

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

47 Citas (Scopus)

Resumen

Bromelain is a key enzyme found in pineapple (Ananas comosus (L.) Merr.); a proteolytic substance with multiple beneficial effects for human health such as anti-inflammatory, immunomodulatory, antioxidant and anticarcinogenic, traditionally used in many countries for its potential therapeutic value. The aim of this updated and comprehensive review focuses on the potential anticancer benefits of bromelain, analyzing the cytotoxic, apoptotic, necrotic, autophagic, immunomodulating, and anti-inflammatory effects in cancer cells and animal models. Detailed information about Bromelain and its anticancer effects at the cellular, molecular and signaling levels were collected from online databases such as PubMed/MedLine, TRIP database, GeenMedical, Scopus, Web of Science and Google Scholar. The results of the analyzed studies showed that Bromelain possesses corroborated pharmacological activities, such as anticancer, anti-edema, anti-inflammatory, anti-microbial, anti-coagulant, anti-osteoarthritis, anti-trauma pain, anti-diarrhea, wound repair. Nonetheless, bromelain clinical studies are scarce and still more research is needed to validate the scientific value of this enzyme in human cancer diseases.

Idioma originalInglés
Número de artículo1068778
PublicaciónFrontiers in Oncology
Volumen12
DOI
EstadoPublicada - 9 ene. 2023
Publicado de forma externa

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

  1. ODS 3: Salud y bienestar
    ODS 3: Salud y bienestar

Huella

Profundice en los temas de investigación de 'Anticancer properties of bromelain: State-of-the-art and recent trends'. En conjunto forman una huella única.

Citar esto